About Pricing FAQs Providers Trials Blog

Back to your record

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Brain Cancer Clinical Trials | 954 Studies Recruiting

Clinical TrialsBrain Cancer

Brain Cancer Clinical Trials

Browse 954 clinical trials for brain cancer. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 21-40 of 954 trials

CompletedDetecting Malignant Brain Tumor Cells in the Bloodstream During Surgery to Remove the TumorGlioblastomas, the most frequent malignant brain tumor in adults, are widespread in the brain, despite their discrete appearance on computed tomography (CT) or magnetic resonance…NCT00001148·Bethesda, Maryland

Related Searches

glioblastomatrials gliomatrials brain tumortrials

Data from ClinicalTrials.govTerms

CompletedRadiation Therapy in Treating Patients With GlioblastomaRATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Drugs such as pentoxifylline and hydroxyurea may make tumor cells more sensitive to radiation therapy.NCT00019058·Bethesda, Maryland

CompletedPioglitazone Hydrochloride in Preventing Radiation-Induced Cognitive Dysfunction in Treating Patients With Brain TumorsRATIONALE: Pioglitazone hydrochloride may be effective treatment for cognitive dysfunction caused by radiation therapy.NCT01151670·Winston-Salem, North Carolina

RecruitingMultitracer [18F]Fluciclovine and 18F-FDG PET, and Advanced MRI for Metabolic Profiling of Glioblastoma* To perform metabolic phenotyping of treatment naïve and recurrent GBM by multitracer \[18F\]Fluciclovine and 18F-FDG PET.NCT06613841·Philadelphia, Pennsylvania and 1 other

UnknownCarmustine in Treating Patients With Progressive or Recurrent Glioblastoma MultiformeRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00006656·Los Angeles, California and 11 others

TerminatedBevacizumab (Avastin) Into the Tumor Resection Cavity in Subjects With Glioblastoma Multiforme at First RecurrenceThis is a phase 1b study for safety and tolerability of bevacizumab(Avastin)administered into the tumor resection cavity in subjects with Glioblastoma Multiforme (GBM) at first…NCT01526837·White Plains, New York

CompletedPerifosine and Torisel (Temsirolimus) for Recurrent/Progressive Malignant GliomasThe purpose of this study is to test the effectiveness of a drug called temsirolimus in combination with a drug called perifosine in treating brain tumors that have continued to…NCT02238496·New York, New York and 1 other

CompletedZoledronate in Preventing Osteoporosis in Patients With Primary Malignant GliomaRATIONALE: Zoledronate may prevent bone loss in patients with primary malignant glioma.NCT00301873·Durham, North Carolina

CompletedHigh-Dose Chemotherapy Plus Autologous Stem Cell Transplantation Compared With Intermediate-Dose Chemotherapy Plus Autologous Stem Cell Transplantation With or Without Isotretinoin in Treating Young Patients With Recurrent High-Grade GliomasRATIONALE: Drugs used in chemotherapy, such as carboplatin, thiotepa, and etoposide, work in different ways to stop tumor cells from dividing so they stop growing or die.NCT00078988·Little Rock, Arkansas and 58 others

TerminatedCilengitide and Sunitinib Malate in Treating Patients With Advanced Solid Tumors or Glioblastoma MultiformeThis clinical trial is studying how well giving cilengitide together with sunitinib malate works in treating patients with advanced solid tumors or glioblastoma multiforme.NCT01122888·Chicago, Illinois

TerminatedTPI 287 in Patients With Recurrent Glioblastoma MultiformeThe goal of this clinical research study is to learn if TPI 287 can help to control glioblastoma. The safety of this drug will also be studied.NCT01113463·Houston, Texas

TerminatedDetermining Dose of Regadenoson Most Likely to Transiently Alter the Integrity of the Blood-Brain Barrier in Patients With High Grade Gliomasenroll patients with histologically confirmed high-grade gliomas to evaluate the ability of regadenoson to transiently disrupt a relatively intact blood-brain barrier (BBB)…NCT03971734·Baltimore, Maryland and 1 other

UnknownArsenic Trioxide, Temozolomide, and Radiation Therapy in Treating Patients With Malignant Glioma That Has Been Removed By SurgeryRATIONALE: Drugs used in chemotherapy, such as arsenic trioxide and temozolomide, work in different ways to stop the growth of tumor cells, either by killing the cells or by…NCT00275067·Chicago, Illinois and 2 others

CompletedSU-101 Compared With Procarbazine in Treating Patients With Glioblastoma MultiformeRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00003293·Phoenix, Arizona and 34 others

CompletedLenalidomide in Treating Young Patients With Recurrent, Progressive, or Refractory CNS TumorsThis phase I trial is studying the side effects and best dose of lenalidomide in treating young patients with recurrent, progressive, or refractory CNS tumors.NCT00100880·Memphis, Tennessee

TerminatedPhase I / II Vorinostat, Erlotinib and Temozolomide for Recurrent Glioblastoma Multiforme (GBM)Phase I Objectives: -To determine the maximum tolerated dose (MTD) of vorinostat + erlotinib versus vorinostat + erlotinib + temozolomide in adult patients with recurrent…NCT01110876·Houston, Texas

CompletedDasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or GliosarcomaThis phase II trial studies how well dasatinib works in treating patients with glioblastoma multiforme or gliosarcoma that has come back.NCT00423735·Mobile, Alabama and 187 others

CompletedPET/CT Evaluation of Primary and Metastatic Brain Tumors With a Novel Radioiodinated Phospholipid Ether Analogue I-NM404The purpose of this study is to evaluate diagnostic imaging techniques using 124I-NM404 PET/CT in human brain tumors.NCT01540513·Madison, Wisconsin

TerminatedOpen-label Trial of Imatinib Mesylate in Patients With Unresectable Recurrent Glioblastoma Multiforme Expressing PDGFR (Platelet Derived Growth Factor Receptors)This is an open label clinical trial of imatinib mesylate 800 mg po/day in a population of patients with unresectable, recurrent glioblastoma multiforme.NCT00171938·Rio Grande

CompletedA Phase I/II Trial of BMS-247550 for Treatment of Patients With Recurrent High-Grade GliomasDrugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00045708·Atlanta, Georgia and 4 others

PreviousPage 2 of 48Next